Trial Details
TERMINATEDBasic Information
| Clinical ID | c2459 |
|---|---|
| Identifier | NCT03462966 |
| Trial Title | Rifaximin on Visceral Hypersensitivity |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Visceral Hypersensitivity|Irritable Bowel Syndrome |
| Interventions | DRUG: Rifaximin |
Participant Information
| Sponsor | Cedars-Sinai Medical Center |
|---|---|
| City | Los Angeles |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2018-07-01 |
|---|---|
| Primary Completion Date | 2021-11-19 |
| Completion Date | 2021-11-19 |